(Q33538232)

27 July 2017

1 reference

title

Strategies to enhance the coexpression of cytochrome P450 2E1 and reductase in bacteria (English)

1 reference

27 July 2017

Porter TD

1

1 reference

27 July 2017

Chang S

series ordinal

2

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

27 July 2017

published in

Drug Metabolism Reviews

1 reference

27 July 2017

volume

31

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

159-174

1 reference

Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties.

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Purification and characterization of recombinant-expressed cytochrome P450 2C3 from Escherichia coli: 2C3 encodes the 6 beta-hydroxylase deficient form of P450 3b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

A universal approach to the expression of human and rabbit cytochrome P450s of the 2C subfamily in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Baculovirus expression of human P450 2E1 and cytochrome b5: spectral and catalytic properties and effect of b5 on the stoichiometry of P450 2E1-catalyzed reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Functional high level expression of cytochrome P450 CYP2D6 using baculoviral expression systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Drug metabolism by Escherichia coli expressing human cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Mutagenesis at a highly conserved phenylalanine in cytochrome P450 2E1 affects heme incorporation and catalytic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Discontinuity of homology of Escherichia coli and Salmonella typhimurium DNA in the lac region

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Purification and properties of a shortened form of cytochrome P-450 2E1: deletion of the NH2-terminal membrane-insertion signal peptide does not alter the catalytic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Participation of rat liver cytochrome P450 2E1 in the activation of N-nitrosodimethylamine and N-nitrosodiethylainine to products genotoxic in an acetyltransferase–overexpressing Salmonella typhimurium strain (NM2009)

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Expression of a catalytically active human cytochrome P-4502E1 in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Expression of cytochrome P450 2D6 in Escherichia coli, purification, and spectral and catalytic characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101912

21 January 2018

Identifiers

DOI

10.1081/DMR-100101912

1 reference

27 July 2017

1 reference